Harnessing PDX and PDX 2.0: the next-generation paradigm for precision oncology and translational breakthroughs
Abstract Cancer research has achieved remarkable breakthroughs over the past decades with the aid of patient-derived xenograft (PDX) models. However, the limitations of conventional PDX models in hindering clinical translation have become increasingly apparent. In 2025, the National Institutes of He...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-02-01
|
| Col·lecció: | Molecular Cancer |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12943-026-02594-w |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|